Promoter holding
64.27%
PP
Pellets Pharma - Due diligence report
A 360° intelligence report on Pellets Pharma: trust score, financial health, credit view, compliance, directors, growth and distress signals…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Pellets Pharma — 360° Intelligence Report
Generated from MCA filings & public records74/100
Trust Score
Moderate
Pellets Pharma is assessed as Moderate with a Trust Score of 74/100. Pellets Pharma is an active public limited indian non-government company incorporated in 2004, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 06 Oct 2026 from the latest processed filings. Pellets Pharma Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
53/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 1 satisfied (25.00 Lakh).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| The Dhanalakshmi Bank Ltd | 1 | 48.0 cr |
Compliance Score: 53/100 Moderate
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2024 - filings overdue.
- Litigation present in 2 court forum(s).
- Delayed payments to MSME suppliers disclosed (2 disclosure(s)).
- 1 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SRINIVASA RAO JETTI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PATHURU SREELATHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PATHURU VAMSI KRISHNA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Pathuru Aasritha | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 4 directors on the board.
- SRINIVASA RAO JETTI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2022 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Key managerial personnel: SRINIVASA RAO JETTI (Whole-time director) · PATHURU SREELATHA (Managing Director) · PATHURU VAMSI KRISHNA (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 75 · Distress 80
Growth signals & trust indicators
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
Operating for 22+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Statutory filings appear overdue.
Compliance score is weak (53/100).
MSME payment delays disclosed - latest outstanding 2.23 Lakh.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence67/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment81/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view80/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2024
Director appointed
SRINIVASA RAO JETTI (Whole-time director)
Director appointed
Pathuru Aasritha (Director)
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
18 Jul 2019
Director appointed
PATHURU VAMSI KRISHNA (Whole-time director)
02 Mar 2019
Director ceased
RADHAKRISHNA PATHURU
08 Jan 2019
Director ceased
PATHURU SREELATHA
21 Mar 2017
Charge satisfied
The Dhanalakshmi Bank Ltd
30 Mar 2009
Securities allotted
45000.00 Equity Shares - 4.50 Lakh raised
11 Mar 2009
Director ceased
GADDIPATI SANKAR BASAVA
Director ceased
MOHAN GADDIPATI RAO
Director ceased
MIKKILINENI PRASAD BHANU
02 Apr 2006
Securities allotted
385277.00 Equity Shares - 38.53 Lakh raised
29 Mar 2005
Charge created
The Dhanalakshmi Bank Ltd - 25.00 Lakh
11 Mar 2004
Incorporated
Registered with Roc Hyderabad
10
Key Observations
Auto-generated from the data aboveRevenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Net worth is positive.
4 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| C-Star Digital Private Limited | U72900TG2019PTC137380 | Hyderabad, Telangana |
| Pyr Developers Private Limited | U45209TG2013PTC090561 | Hyderabad, Telangana |
| Oxy People Foundation | U80904TG2022NPL169374 | Hyderabad, Telangana |
| Little Laughs Learning Private Limited | U85500TS2023PTC178902 | Hyderabad, Telangana |
| Spansule (India) Private Limited | U24239TG1999PTC031707 | Hyderabad, Telangana |
| Vty Triksha Health Tech Private Limited | U62013TS2024PTC190690 | Hyderabad, Telangana |
| Fastra Corporation Private Limited | U72900TG2017PTC116928 | Hyderabad, Telangana |
| Thinkshastra Edu Solutions Private Limited | U72200TG2011PTC075636 | Hyderabad, Telangana |
| Advintto Private Limited | U74999TG2020PTC140950 | Hyderabad, Telangana |
| Ideyalabs Private Limited | U72900TG2022PTC161391 | Hyderabad, Telangana |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Pellets Pharma before audits and certifications: compliance score 53/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Pellets Pharma: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Pellets Pharma - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Pellets Pharma pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Pellets Pharma - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Pellets Pharma an active company?
Pellets Pharma has MCA status “Active” with a compliance score of 53/100 (Moderate).
Is Pellets Pharma financially healthy?
Pellets Pharma has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Pellets Pharma?
Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Pellets Pharma?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.
Does Pellets Pharma have loans or charges against its assets?
No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Pellets Pharma up to date with its ROC filings?
Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 53/100 (Moderate).
Is it risky to lend to Pellets Pharma?
Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
